Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GV Innovation High-Value Niche Market Transformation Project 2024-05-29 20:30
HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max 2024-05-29 19:30
Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024 2024-05-29 17:55
Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024 2024-05-29 17:35
Frost & Sullivan Reported The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics 2024-05-29 14:08
Spectacular advances creating a revolution in the diagnosis and treatment of male infertility 2024-05-29 12:42
US-Based Neurobiotic Leader Bened Life Launches Global Expansion with Neuralli™ MP 2024-05-29 10:00
US-Based Neurobiotic Leader Bened Life enters Japan market with Neuralli™ MP 2024-05-29 10:00
TREEFROG THERAPEUTICS PICKS-UP BEST POSTER AWARD AT THE INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY (ISCT) ANNUAL MEETING FOR THEIR CELL THERAPY PROGRAM IN PARKINSON'S DISEASE 2024-05-29 06:00
GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor 2024-05-28 23:00
Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD 2024-05-28 23:00
Metabolon Now Includes Spectral Data Files for All Global Discovery Panel Projects 2024-05-28 21:00
HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases 2024-05-28 19:00
Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies 2024-05-28 19:00
Stavian Chemical Ranks 17th in ICIS Top 100, Signaling Strong Growth Amid Global Market Challenges 2024-05-28 10:00
Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA 2024-05-28 08:00
Telix Submits NDA for New Prostate Cancer Imaging Agent 2024-05-27 07:21
Critical need for doctors to counsel couples on potential genetic burden in offspring of older dads 2024-05-26 15:59
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual Meeting 2024-05-24 22:00
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024 2024-05-24 20:00
1 32 33 34 35 36 451